Management of the Anticoagulated Patient with Life-Threatening Bleeding in the ED: An Interactive, Case-based Approach - Day 1


Day 1
Wednesday, May 13th, 2020
12:00 p.m. – 1:00 p.m.
Room Location: Sliver Room- Mezzanine Level
*Lunch Provided


PancioliArthur M. Pancioli, MD - University of Cincinnati -  Indications for Anticoagulation and Agents: Coumadin, Factor IIa & Factor Xa Inhibitors


Natalie P. Kreitzer, MD University of Cincinnati EM/Neurocritical Care, Intracranial and Intraspinal Bleeding in the Anticoagulated Patient



Hoekstra James fullJames W. Hoekstra, MD Wake Forest University, Treatment of Severe Gastrointestinal in the Anticoagulated Patient

GregFermannGregory J. Fermann, MD - University of Cincinnati -

Management of Life-Threatening Bleeding in the Anticoagulated ED Patient

Disclosures: Speakers Bureau/Consulting: Janssen Pharmaceuticals; Research Support: Portola Pharmaceuticals

W. Brian Gibler, MD - University of Cincinnati (Moderator), Case PResentations/ AUdience Question and Answer/Panel Discussion.
Disclosures: Advisory Board: AstraZeneca, Entegrion; Shareholder: MyocardioCare, Entegrion

Using a case-based, highly interactive approach with the Emergency Physician audience, this 1st day EMCREG-International Symposium will describe the indications for anticoagulation, pharmacologic agents, and reversal agents in the ED as well as emphasis on two major sources of severe bleeding  with significant morbidity and mortality – intracranial/intraspinal bleeding and gastrointestinal bleeding. 

Learning Objectives:

At the conclusion of this symposium, attendees will be able to:

1) Describe the indications for anticoagulation and agents including coumadin, Factor IIa, and Factor Xa inhibitors;

2) Identify and integrate the management of the anticoagulated patient in the ED and ICU; and

3) Compare and contrast the treatment of intracranial, intraspinal, and gastrointestinal bleeding in the anticoagulated patient.

Accreditation Statement:

The University of Cincinnati College of Medicine Office of Continuing Medical Education is accrediting this 1 hour symposium for 1 (one) hour of Category 1 ACCME credit.